Not applicableUnknownNCT03166241
What this trial is testing
Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.
Who this might be right for
Adverse Cutaneous Reaction to Alternative Medical Therapy
Assiut University 30